- Report
- September 2025
- 150 Pages
Global
From €4486EUR$4,850USD£3,744GBP
- Training
- November 2026
- 90 Minutes
Global
- Report
- October 2026
- 64 Pages
Saudi Arabia
From €647EUR$700USD£540GBP
- Report
- August 2026
- 43 Pages
United States
From €518EUR$560USD£432GBP
€647EUR$700USD£540GBP
- Report
- January 2026
- 40 Pages
Vietnam
From €2775EUR$3,000USD£2,316GBP
- Report
- October 2025
- 90 Pages
Kuwait
From €4162EUR$4,500USD£3,473GBP
- Report
- October 2025
- 99 Pages
Middle East
From €4162EUR$4,500USD£3,473GBP
- Report
- March 2025
- 130 Pages
Global
From €4486EUR$4,850USD£3,744GBP
- Report
- January 2025
- 388 Pages
Global
From €2488EUR$2,690USD£2,076GBP
- Report
- July 2024
- 90 Pages
China
From €1665EUR$1,800USD£1,389GBP
- Report
- January 2024
- 213 Pages
Global
From €4301EUR$4,650USD£3,589GBP
- Report
- September 2023
- 89 Pages
From €2729EUR$2,950USD£2,277GBP
- Report
- September 2023
- 101 Pages
North America
From €2729EUR$2,950USD£2,277GBP
- Report
- September 2023
- 114 Pages
Global
From €2729EUR$2,950USD£2,277GBP
- Report
- September 2023
- 194 Pages
Global
From €4578EUR$4,950USD£3,821GBP
- Report
- September 2023
- 112 Pages
Europe
From €3191EUR$3,450USD£2,663GBP
- Report
- September 2023
- 107 Pages
Asia Pacific
From €3191EUR$3,450USD£2,663GBP
- Report
- March 2023
- 185 Pages
Global
From €2312EUR$2,500USD£1,930GBP
- Report
- December 2022
- 77 Pages
Global
From €4578EUR$4,950USD£3,821GBP
- Report
- September 2022
- 110 Pages
Global
From €5087EUR$5,500USD£4,245GBP
The Vaccine Manufacturing market is a subset of the biopharmaceutical industry, which focuses on the development and production of vaccines. Vaccines are biological products that are used to prevent and treat infectious diseases. Vaccine manufacturing involves the production of active ingredients, such as antigens, as well as the formulation and packaging of the final product. Vaccine manufacturers must adhere to strict regulatory standards to ensure the safety and efficacy of their products.
The Vaccine Manufacturing market is highly competitive, with a number of large pharmaceutical companies and biotechnology firms competing for market share. Companies in the market include Merck & Co., GlaxoSmithKline, Sanofi, Pfizer, Johnson & Johnson, and Novavax. Show Less Read more
